Medilink will be hosting a webinar with Mills & Reeve where they will discuss the Medicines and Medical Devices Bill and the UK regulatory environment after Brexit.
As the end of the Brexit transition period approaches, the UK government is making plans to move forward as a standalone regulatory system. A central plank of these plans is the Medicines and Medical Devices Bill.
This was published in February and is making its way through the Parliamentary process. Although existing EU law will be brought over into the UK system from 1 January 2021, the Bill gives broad powers to the health minister to develop the law to fit UK priorities. Promoting fast-track approval of innovative medicines and technologies and reducing red tape, as well as promoting UK-based industry, will take on greater importance.
For medical devices, the situation is made more complex by the forthcoming full implementation of the new EU regulations on medical devices and in vitro diagnostics. Likewise, the EU clinical trials system is yet to be rolled out pending completion of the EMA’s new portal and database. The UK will have to decide how closely to track these systems, while adopting its own administrative structures to implement them.
The webinar will review the latest position and consider likely outcomes for the UK regulatory environment on Tuesday 1 December.
You can book your place for the webinar, here.
